Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly's Cymbalta Label Adds Postmarketing Data On Hepatotoxicity

Oct 17 2005

• By Turna Ray

Related Content

Cymbalta Approved; Lilly Antidepressant Will Be Available By Late August

Aug 04 2004

Duloxetine Drug Interactions Are Issue For Yentreve, But Not For Cymbalta

Nov 29 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window